Bandingkan Harga & Kinerja Maxindo Karya Anugerah Tbk. (MAXI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Maxindo Karya Anugerah Tbk. dan Organon Pharma Indonesia Tbk.: Maxindo Karya Anugerah Tbk. diperdagangkan di Rp50 (kapitalisasi pasar 480,5 M, volume 24 jam 43,8 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Maxindo Karya Anugerah Tbk. jauh lebih besar — sekitar 4,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MAXI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 480,5 M | 104,4 M |
Volume | 43,8 rb | — |
Lot | 438 | — |
Perputaran | 2,19 jt | — |
Harga Rata-rata | 50 | — |
Nilai Transaksi | 2,19 jt | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Maxindo Karya Anugerah Tbk.
PT Maxindo Karya Anugerah Tbk (the Company) was established based on Notarial Deed No. 26 of Dwi Swandiani, S.H., dated July 11, 2002. The Company started its commercial operations in 2002.
Selengkapnya di halaman MAXI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
